KRSNA Diagnostics (Mumbai) Private Limited has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011.
KRSNAA · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
KRSNA Diagnostics (Mumbai) Private Limited, a promoter group entity of Krsnaa Diagnostics, has filed its annual declaration with the stock exchanges under SEBI's Takeover Regulations. The entity confirmed that neither it nor any person acting in concert has created any encumbrance (pledge, lien, or charge) on the shares held by them, directly or indirectly, during the financial year ended March 31, 2025. This is a routine yearly compliance filing required from promoter group entities, and the declaration indicates a clean status with no pledging activity. The letter was signed by Director Sunita Rajendra Mutha.
This is a neutral-to-positive signal for shareholders, as the absence of new encumbrances means the promoter group has not pledged any shares during the year, reducing concerns about potential forced selling or margin call risks. No material impact on stock price is expected from this routine compliance disclosure.